K
Kazunori Nakase
Researcher at Mie University
Publications - 79
Citations - 1573
Kazunori Nakase is an academic researcher from Mie University. The author has contributed to research in topics: Leukemia & Myeloid leukemia. The author has an hindex of 21, co-authored 77 publications receiving 1486 citations. Previous affiliations of Kazunori Nakase include Westmead Hospital.
Papers
More filters
Journal ArticleDOI
Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34.
Kenkichi Kita,Kazunori Nakase,Hiroshi Miwa,Masahiro Masuya,Kazuhiro Nishii,Morita N,Nobuyuki Takakura,A Otsuji,Shigeru Shirakawa,T Ueda +9 more
TL;DR: The findings indicate that leukemic blasts of t(8;21) AML commonly express CD19 while preserving the stem cell-associated antigens, and differentiate into the granulocytic pathway with discordant maturation such as low CD33 expression.
Journal ArticleDOI
Fatal Trichosporon fungemia in patients with hematologic malignancies.
Kei Suzuki,Kazunori Nakase,Taiichi Kyo,Tadahiro Kohara,Yumiko Sugawara,Tetsunori Shibazaki,Kouji Oka,Tetsuya Tsukada,Naoyuki Katayama +8 more
TL;DR: At present, the diagnosis of invasive trichosporonosis depends on blood culture studies, and the mortality of this disease is high; however, azole therapy and control of blood glucose level, together with hematopoietic recovery could help in improving the clinical outcome.
Journal ArticleDOI
Clinical Importance of CD7 Expression in Acute Myelocytic Leukemia
Kenkichi Kita,Hiroshi Miwa,Kazunori Nakase,Keiki Kawakami,Tohru Kobayashi,Shigeru Shirakawa,Isao Tanaka,Chizuko Ohta,Hiroshi Tsutani,Oguma S,Taiichi Kyo,Hiroo Dohy,Nanao Kamada,Kaori Nasu,Haruto Uchino +14 more
TL;DR: In this article, 40 patients with CD7 + acute myelocytic leukemia (AML) were investigated; they were classified into the following subgroups according to French-American-British classification: 15 M1, 18 M2, 3 M4, and 4 MS.
Journal Article
Clinical importance of CD7 expression in acute myelocytic leukemia. The Japan Cooperative Group of Leukemia/Lymphoma
Kenkichi Kita,Hiroshi Miwa,Kazunori Nakase,Keiki Kawakami,Kobayashi T,Shigeru Shirakawa,Isao Tanaka,C Ohta,Hiroshi Tsutani,Oguma S +9 more
TL;DR: The results presented here indicate the diagnostic importance ofCD7 positivity in AML, suggesting that the cellular and clinical characteristics of CD7+ AML are sufficient for it to be recognized as a distinct category of AML.
Journal ArticleDOI
Clinical importance of CD7 expression in acute myelocytic leukemia. The Japan Cooperative Group of Leukemia/Lymphoma [see comments]
Kenkichi Kita,Hiroshi Miwa,Kazunori Nakase,Keiki Kawakami,Kobayashi T,Shigeru Shirakawa,Tanaka I,C Ohta,H Tsutani,S Oguma +9 more
TL;DR: Patients with CD7+ acute myelocytic leukemia (AML) were investigated; they were classified into the following subgroups according to French-American-British classification: 15 M1, 18 M2, 3 M4, and 4 M5.